108 related articles for article (PubMed ID: 22293800)
61. An Empirical Study on Diabetes Depression over Distress Evaluation Using Diagnosis Statistical Manual and Chi-Square Method.
Noman SM; Arshad J; Zeeshan M; Rehman AU; Haider A; Khurram S; Cheikhrouhou O; Hamam H; Shafiq M
Int J Environ Res Public Health; 2021 Apr; 18(7):. PubMed ID: 33916851
[TBL] [Abstract][Full Text] [Related]
62. [The association between diabetes complications and symptoms of depression and anxiety].
Hargittay C; Vörös K; Eőry A; Márkus B; Szabó G; Rihmer Z; Gonda X; Torzsa P
Orv Hetil; 2023 Jan; 164(3):79-87. PubMed ID: 36681997
[TBL] [Abstract][Full Text] [Related]
63. The relationship between diabetes-related emotional distress and illness perceptions among Indian patients with Type II diabetes.
Chittem M; Chawak S; Sridharan SG; Sahay R
Diabetes Metab Syndr; 2019; 13(2):965-967. PubMed ID: 31336552
[TBL] [Abstract][Full Text] [Related]
64. Insulin mediated improvement in glycemic control in elderly with type 2 diabetes mellitus can improve depressive symptoms and does not seem to impair health-related quality of life.
Oliveira RA; Tostes M; Queiroz VA; Rodacki M; Zajdenverg L
Diabetol Metab Syndr; 2015; 7():55. PubMed ID: 26110026
[TBL] [Abstract][Full Text] [Related]
65. Exploring the relationship between diabetes self-efficacy, depressive symptoms, and glycemic control among men and women with type 2 diabetes.
Cherrington A; Wallston KA; Rothman RL
J Behav Med; 2010 Feb; 33(1):81-9. PubMed ID: 20128112
[TBL] [Abstract][Full Text] [Related]
66. Resourcefulness and health practices of diabetic women.
Zauszniewski JA; Chung C
Res Nurs Health; 2001 Apr; 24(2):113-21. PubMed ID: 11353459
[TBL] [Abstract][Full Text] [Related]
67. Hopelessness depression as a distinct dimension of depressive symptoms among clinical and non-clinical samples.
Joiner TE; Steer RA; Abramson LY; Alloy LB; Metalsky GI; Schmidt NB
Behav Res Ther; 2001 May; 39(5):523-36. PubMed ID: 11341249
[TBL] [Abstract][Full Text] [Related]
68. Impact of treatment modalities on quality of life and depression in type 2 diabetes.
Lackovic MM; Macvanin MT; Obradovic MM; Gluvic ZM; Sudar-Milovanovic EM; Sipetic Grujicic SB; Isenovic ER
Eur Rev Med Pharmacol Sci; 2023 Jun; 27(11):4980-4989. PubMed ID: 37318472
[TBL] [Abstract][Full Text] [Related]
69. Assessment of factors associated with the quality of life in Korean type 2 diabetic patients.
Chung JO; Cho DH; Chung DJ; Chung MY
Intern Med; 2013; 52(2):179-85. PubMed ID: 23318846
[TBL] [Abstract][Full Text] [Related]
70. Selected factors determining a way of coping with stress in type 2 diabetic patients.
Sobol-Pacyniak AB; Szymczak W; Kwarta P; Loba J; Pietras T
Biomed Res Int; 2014; 2014():587823. PubMed ID: 25105132
[TBL] [Abstract][Full Text] [Related]
71. Prevalence of depression in type 2 diabetes mellitus.
Rodríguez Calvín JL; Zapatero Gaviria A; Martín Ríos MD
Rev Clin Esp (Barc); 2015 Apr; 215(3):156-64. PubMed ID: 25432144
[TBL] [Abstract][Full Text] [Related]
72. Severity of depressive but not anxiety symptoms impacts glucose metabolism among patients with type 2 diabetes in primary care.
Hargittay C; Eöry A; Márkus B; Mohos A; Ferenci T; Vörös K; Rihmer Z; Gonda X; Torzsa P
Front Med (Lausanne); 2022; 9():944047. PubMed ID: 35966882
[TBL] [Abstract][Full Text] [Related]
73. Depressive symptoms and disorders in type 2 diabetes mellitus.
Mukherjee N; Chaturvedi SK
Curr Opin Psychiatry; 2019 Sep; 32(5):416-421. PubMed ID: 31135489
[TBL] [Abstract][Full Text] [Related]
74. Emotional dysfunction associated with diabetes in Mexican adolescents and young adults with type-1 diabetes.
Lerman-Garber I; Barrón-Uribe C; Calzada-León R; Mercado-Atri M; Vidal-Tamayo R; Quintana S; Hernández ME; Ruiz-Reyes Mde L; Tamez-Gutiérrez LE; Nishimura-Meguro E; Villa AR
Salud Publica Mex; 2003; 45(1):13-8. PubMed ID: 12649957
[TBL] [Abstract][Full Text] [Related]
75. Depression and quality of life in patients with type 2 diabetes mellitus.
Bayani MA; Shakiba N; Bijani A; Moudi S
Caspian J Intern Med; 2022; 13(2):335-342. PubMed ID: 35919653
[TBL] [Abstract][Full Text] [Related]
76. Association Between Lipophilic Beta-Blockers and Depression in Diabetic Patients on Chronic Dialysis.
Lengton R; W Schouten R; Nadort E; van Rossum EF; Dekker FW; Siegert CE; Hoogeveen EK
Clin Med Insights Endocrinol Diabetes; 2022; 15():11795514221119446. PubMed ID: 36061232
[TBL] [Abstract][Full Text] [Related]
77. Going Beyond the Visible in Type 2 Diabetes Mellitus: Defense Mechanisms and Their Associations With Depression and Health-Related Quality of Life.
Martino G; Caputo A; Bellone F; Quattropani MC; Vicario CM
Front Psychol; 2020; 11():267. PubMed ID: 32174865
[TBL] [Abstract][Full Text] [Related]
78. Monitoring of Individual Needs in Diabetes (MIND)-2: follow-up data from the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) MIND study.
Snoek FJ; Kersch NY; Eldrup E; Harman-Boehm I; Hermanns N; Kokoszka A; Matthews DR; McGuire BE; Pibernik-Okanović M; Singer J; de Wit M; Skovlund SE
Diabetes Care; 2012 Nov; 35(11):2128-32. PubMed ID: 22837364
[TBL] [Abstract][Full Text] [Related]
79. Relationship between Opium Abuse and Severity of Depression in Type 2 Diabetic Patients.
Zahra S; Hossein S; Ali KV
Diabetes Metab J; 2012 Apr; 36(2):157-62. PubMed ID: 22540053
[TBL] [Abstract][Full Text] [Related]
80. Study of emotional distress in a comparative effectiveness trial of diabetes treatments: Rationale and design.
Cherrington AL; Krause-Steinrauf H; Bebu I; Naik AD; Walker E; Golden SH; Gonzalez JS;
Contemp Clin Trials; 2021 Aug; 107():106366. PubMed ID: 33766761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
